bf/NYSE:HAE_icon.png

COM:HAEMONETICS

Haemonetics Corporation

  • Stock

Last Close

75.38

30/08 20:00

Market Cap

3.87B

Beta: -

Volume Today

583.13K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Apr '16
Apr '17
Mar '18
Mar '19
Mar '20
Apr '21
Apr '22
Apr '23
Mar '24
revenue
938.51M
-
910.37M
3.00%
909.67M
0.08%
886.12M
2.59%
903.92M
2.01%
967.58M
7.04%
988.48M
2.16%
870.46M
11.94%
993.20M
14.10%
1.17B
17.67%
1.31B
12.01%
cost of revenue
470.14M
-
475.95M
1.24%
503.80M
5.85%
507.62M
0.76%
492.01M
3.07%
550.04M
11.79%
503.97M
8.38%
472.63M
6.22%
487.69M
3.19%
553.56M
13.51%
632.49M
14.26%
gross profit
468.37M
-
434.42M
7.25%
405.87M
6.57%
378.49M
6.75%
411.91M
8.83%
417.54M
1.37%
484.51M
16.04%
397.84M
17.89%
505.50M
27.06%
615.10M
21.68%
676.57M
9.99%
selling and marketing expenses
4.50M
-
4.30M
4.44%
2.70M
37.21%
4.40M
62.96%
7.20M
63.64%
general and administrative expenses
293.78M
-
295.38M
0.55%
271.49M
8.09%
335.16M
23.45%
369.48M
10.24%
selling general and administrative expenses
366.84M
-
339.69M
7.40%
323.97M
4.63%
301.73M
6.87%
316.52M
4.90%
298.28M
5.76%
299.68M
0.47%
274.19M
8.51%
339.56M
23.84%
376.68M
10.93%
431.78M
14.63%
research and development expenses
54.20M
-
54.19M
0.02%
45.56M
15.91%
37.56M
17.58%
39.23M
4.45%
35.71M
8.96%
30.88M
13.53%
32.86M
6.39%
46.80M
42.44%
50.13M
7.12%
54.44M
8.59%
other expenses
1.71M
-
5.44M
218.00%
87.67M
1,511.25%
-8.10M
109.23%
50.60M
-
32.83M
35.12%
47.41M
44.42%
32.26M
31.97%
40.45M
25.40%
cost and expenses
891.18M
-
869.83M
2.40%
873.34M
0.40%
846.90M
3.03%
847.77M
0.10%
884.03M
4.28%
834.53M
5.60%
812.50M
2.64%
921.47M
13.41%
459.06M
50.18%
1.12B
143.69%
operating expenses
421.04M
-
393.88M
6.45%
369.54M
6.18%
339.28M
8.19%
355.75M
4.85%
333.99M
6.12%
330.56M
1.03%
339.88M
2.82%
433.78M
27.63%
459.06M
5.83%
486.21M
5.91%
interest expense
10.93M
-
9.38M
14.20%
9.47M
1.06%
8.10M
14.56%
4.53M
44.10%
9.91M
119.05%
16.20M
63.43%
16.83M
3.92%
17.12M
1.70%
14.63M
14.55%
-13.02M
188.98%
ebitda
47.33M
-
40.54M
14.34%
126.37M
211.72%
128.94M
2.04%
145.40M
12.76%
192.96M
32.71%
264.24M
36.94%
142.25M
46.17%
169.47M
19.14%
249.34M
47.13%
319.60M
28.18%
operating income
47.33M
-
40.54M
14.34%
-43.98M
208.49%
-19.38M
55.94%
56.16M
389.75%
83.55M
48.77%
153.95M
84.27%
57.96M
62.35%
80.75M
39.31%
156.03M
93.23%
190.35M
22.00%
depreciation and amortization
81.74M
-
86.05M
5.28%
90.03M
4.63%
89.73M
0.33%
89.25M
0.54%
109.42M
22.60%
110.29M
0.80%
84.29M
23.58%
88.72M
5.26%
93.31M
5.17%
129.25M
38.52%
total other income expenses net
-1.71M
-
-5.44M
218.00%
-80.32M
1,376.22%
-58.59M
27.05%
8M
113.65%
-9.91M
223.90%
-66.80M
573.91%
14.95M
122.38%
-17.12M
214.52%
-14.63M
14.55%
-38.49M
163.08%
income before tax
36.40M
-
31.16M
14.38%
-53.46M
271.53%
-27.48M
48.60%
59.63M
317.03%
73.63M
23.48%
87.15M
18.36%
72.91M
16.34%
63.63M
12.73%
141.40M
122.23%
151.87M
7.40%
income tax expense
1.25M
-
14.27M
1,038.71%
2.16M
84.84%
-1.21M
155.85%
14.06M
1,263.91%
18.61M
32.39%
10.63M
42.91%
-6.56M
161.70%
20.25M
408.94%
26.00M
28.38%
34.31M
31.94%
net income
35.15M
-
16.90M
51.93%
-55.62M
429.17%
-26.27M
52.77%
45.57M
273.49%
55.02M
20.73%
76.53M
39.09%
79.47M
3.85%
43.38M
45.42%
115.40M
166.05%
117.56M
1.87%
weighted average shs out
51.61M
-
51.53M
0.15%
50.91M
1.21%
51.51M
1.17%
52.76M
2.43%
51.53M
2.32%
50.69M
1.63%
50.69M
0.01%
51.05M
0.71%
50.78M
0.52%
50.71M
0.15%
weighted average shs out dil
52.38M
-
52.09M
0.55%
50.91M
2.26%
51.52M
1.21%
53.50M
3.84%
52.94M
1.04%
51.81M
2.13%
51.29M
1.01%
51.35M
0.12%
51.42M
0.13%
51.40M
0.04%
eps
0.68
-
0.33
51.47%
-1.09
430.30%
-0.51
53.21%
0.86
268.63%
1.07
24.42%
1.51
41.12%
1.57
3.97%
0.85
45.86%
2.27
167.06%
2.32
2.20%
epsdiluted
0.67
-
0.32
52.24%
-1.09
440.63%
-0.51
53.21%
0.85
266.67%
1.04
22.35%
1.48
42.31%
1.55
4.73%
0.84
45.81%
2.24
166.67%
2.29
2.23%

All numbers in (except ratios and percentages)